LCTX
Lineage Cell Therapeutics, Inc.
$1.01
-1.94%
-0.02
Notify me if price changes either direction
Buy LCTX stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Lineage Cell Therapeutics, Inc. (LCTX)
Loading
Key Stats
Market cap.
260.5M
Enterprise value
210.8M
Trailing PE
-3.625
Forward PE
-7.4909086
PEG Ratio
0.033660714285714
Enterprise to EBITDA
-8.075
Enterprise to revenue
16.116
Price to book MRQ
4.273859
Price to sales TTM
19.910929
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-06-30
Revenue (TTM)
13.1M
EBITDA
27.4M
Diluted EPS TTM
-0.19
Total Cash (MRQ)
50.8M
Current ratio (MRQ)
6.608
Operating Cash Flow (TTM)
-23816000
LCTX trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
October 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
